A significant study from the University of Cambridge finds that everyday pesticides and industrial chemicals can kill beneficial gut bacteria, potentially harming digestion, immunity, and overall health.
A new AI tool rolled out across 70+ hospitals in England is helping doctors spot deadly clots faster, doubling thrombectomy rates and giving thousands of stroke patients a better shot at recovery.
The UK launches its first National Centre for Neurotechnology and Neurorestoration in Newcastle to advance cutting-edge treatments and clinical trials for people living with neurological conditions.
The University of Nottingham unveils the world's first mobile quantum brain scanner, designed to monitor the impact of blast exposure on the brain in real time.
Superintendent Pharmacist James O’Loan outlines the everyday challenges faced by individuals living with diabetes and how improvements in digital health are helping to improve management and care.
A UK inquiry finds that around 23,000 deaths in England could have been prevented if the national lockdown had begun a week earlier in March 2020, highlighting major government failings during the pandemic.
Contributors from the PKU community, including patient reps, key opinion leaders, and medical experts, discuss the implications of redefining ‘unmet medical need’ in the EU’s pharmaceutical legislation, emphasising the potential negative impact on patients, particularly those with rare diseases like phenylketonuria.
Successful root canal treatment could lower inflammation, blood sugar, and cholesterol, potentially reducing the risk of heart disease and type 2 diabetes, according to King’s College London research.
A pioneering study, the Elevated Childhood Lead Interagency Prevalence Study (ECLIPS), has launched in Leeds to screen children aged 1–6 for lead exposure using home-based finger‑prick blood tests, soil and dust sampling, and surveys.
Researchers at Mayo Clinic have created a new prediction model combining age, sex, genetic markers, and brain amyloid levels to estimate an individual's lifetime risk of Alzheimer's or mild cognitive impairment,
A global survey by the International Diabetes Federation shows that 40 % of employees with diabetes face negative treatment at work, with many considering leaving their jobs due to stigma and lack of support.
A major trial led by the University of Bristol and North Bristol NHS Trust is exploring a panel of blood tests to detect dementia faster and more accurately across diverse UK populations.
Scientists at Osaka Metropolitan University have unlocked a new way to regenerate bone using fat-derived stem cells, successfully healing spinal fractures in rats.
Researchers at the University of Nottingham have used a lightweight, wearable OPM‑MEG brain scanner to uncover distinct brain‐function changes in people with Multiple Sclerosis, a non‑invasive advance that could improve diagnosis and tracking of disease progression.
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a new framework signalling a significant overhaul of how rare disease treatments are tested, approved, and delivered in the UK.
